ZNF566 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.944200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.171000E-01
Normal-vs-Stage2
5.281500E-02
Normal-vs-Stage3
2.179700E-02
Normal-vs-Stage4
4.619000E-01
Stage1-vs-Stage2
2.769400E-01
Stage1-vs-Stage3
1.607380E-01
Stage1-vs-Stage4
8.696000E-01
Stage2-vs-Stage3
2.851800E-01
Stage2-vs-Stage4
2.539200E-01
Stage3-vs-Stage4
8.384100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.526200E-02
Normal-vs-AfricanAmerican
2.930800E-01
Normal-vs-Asian
1.168960E-01
Caucasian-vs-AfricanAmerican
4.636200E-01
Caucasian-vs-Asian
5.996400E-01
AfricanAmerican-vs-Asian
4.404800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.214100E-02
Normal-vs-Female
6.626300E-02
Male-vs-Female
3.835600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.975800E-01
Normal-vs-Age(41-60Yrs)
1.403030E-01
Normal-vs-Age(61-80Yrs)
5.248100E-02
Normal-vs-Age(81-100Yrs)
1.784400E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.019200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.087800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.661710E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.608500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.513570E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.260000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.061800E-02
Normal-vs-Daily Drinker
3.611600E-02
Normal-vs-Weekly Drinker
1.243890E-02
Normal-vs-Occasional Drinker
9.173600E-02
Normal-vs-Social Drinker
1.625020E-01
Non Drinker-vs-Daily Drinker
9.052400E-01
Non Drinker-vs-Weekly Drinker
9.091000E-01
Non Drinker-vs-Occasional Drinker
1.252160E-01
Non Drinker-vs-Social Drinker
2.305200E-01
Daily Drinker-vs-Weekly Drinker
8.380400E-01
Daily Drinker-vs-Occasional Drinker
1.438850E-01
Daily Drinker-vs-Social Drinker
2.507800E-01
Weekly Drinker-vs-Occasional Drinker
1.817350E-01
Weekly Drinker-vs-Social Drinker
3.231200E-01
Occasional Drinker-vs-Social Drinker
9.047600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.614840E-01
Normal-vs-Grade 2
1.398210E-01
Normal-vs-Grade 3
1.276450E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.585000E-01
Grade 1-vs-Grade 3
2.689600E-01
Grade 1-vs-Grade 4
1.614840E-01
Grade 2-vs-Grade 3
6.419600E-01
Grade 2-vs-Grade 4
1.398210E-01
Grade 3-vs-Grade 4
1.276450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.844160E-02
Normal-vs-NonDiabetic
4.399600E-02
Diabetic-vs-NonDiabetic
3.529400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.296900E-03
Normal-vs-NoPancreatitis
3.379500E-02
Pancreatitis-vs-NoPancreatitis
1.047610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.261500E-02
Normal-vs-N1
5.636000E-02
N0-vs-N1
7.414400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.339800E-02
Normal-vs-TP53-NonMutant
3.498400E-01
TP53-Mutant-vs-TP53-NonMutant
4.986500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
